Cipla invests £100M in UK; BioMarin gets drug approved in Canada; FDA will talk about social media;

@FiercePharma: Our newest site, FierceAnimalHealth, is up and running! Go look --> FierceAnimalHealth.com | Follow @FiercePharma

@EricPFierce: India generic makers, tired of being criticized will see if a PR campaign in the US can turn things around. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: RT @FiercePharma: Top-read in FierceVaccines: Agenus' genital herpes vax cuts viral load 75% in PhII. More | Follow @CarlyHFierce

> Hospira ($HSP) has completed its $250 million acquisition of an active pharmaceutical ingredient plant and R&D facilities from India's Orchid Chemicals & Pharmaceuticals. Release

> There are some lessons in the FDA's approval of generic Copaxone. Blog post

> Cipla says it will invest £100 million into its U.K. subsidiary. Release

> Novo Nordisk ($NVO) has started a share repurchase program, part of its plans to buy back DKK 15.0 billion ($2.7 billion) worth of shares in 2014. Release

> Indian drugmaker Lupin says it has started plans to open U.S. R&D centers in Florida and Maryland to concentrate on complex and inhalation therapies. Story

> BioMarin ($BMRN) gets approval in Canada for treatment for rare disease Morquio A syndrome. Announcement

> The FDA is holding a Webinar on social media guidance for the industry. Register

Medical Device News

@FierceMedDev: Do you know which med tech CEOs made the most money in 2013? Check out our report by @EmilyWFierce and @EmilyMFierce. Feature | Follow @FierceMedDev

@StacyALawrence: 2013's 10 highest-paid Med Tech CEOs - FierceMedicalDevices. Report | Follow @StacyALawrence

@VarunSaxena2: ICYMI: Patent office nomination for J&J top IP lawyer would send anti-reform message. Article | Follow @VarunSaxena2

@MichaelGFierce: A tiny, "walking" robot powered by a muscle cell? It could help deliver drugs one day. FierceDrugDelivery story | Follow @MichaelGFierce

@EmilyWFierce: Effects of childhood trauma and adversity could be mistaken for ADHD, according to experts. More from The Atlantic | Follow @EmilyWFierce

> Senators call on White House to release FDA guidance on lab-developed tests. Story

> Study: Insulin pumps control glucose better than daily shots for Type 2 diabetics. More

> FDA unveils HeartWare warning letter for company's ventricular assist device. Report

> Boston Scientific backs Israeli cardio device startup Mvalve with $15M. News

Biotech News

@FierceBiotech: $ENDP, $BDSI buoyed as PhIII pain drug success clears path to FDA. News | Follow @FierceBiotech

@JohnCFierce: FDA gives an early OK to lymphoma drug Beleodaq. Story | Follow @JohnCFierce

@DamianFierce: I have no idea what the next move for the Aragon/Seragon team is, but do note that Paragon Pharma is already taken. More | Follow @DamianFierce

@EmilyMFierce: Not to mention other zoonotic diseases. RT : We Are Making Ebola Outbreaks Worse By Cutting Down Forests. Article | Follow @EmilyMFierce

> Where's the U.K. outrage over AbbVie's pursuit of Shire? More

> Anti-PD-1 cancer star nivolumab wins world's first regulatory approval. News

> Essex Woodlands strides to a new $750M venture fund for biotech, healthcare. Article

CRO News

> AMRI eyes a big year after completing another buyout. Article

> Quintiles extends its commercial capabilities with Encore buyout. News

> Catalent eyes a Japanese expansion after 40 years in the country. More

> BioOutsource plots a U.S. expansion with eyes on biosimilars. Story

> Parexel eyes the Middle East with its latest CRO buyout. Article

Biotech IT News

> The Silicon Valley startups aiming to build Amazon for biotech R&D. Story

> FDA wants an EMR database to boost oversight of drug safety. More

> FDA IT modernization push set to continue under 2014-2018 strategic plan. Article

> 'Painful' regulations keeping Google on the periphery of life sciences. Story

> Faculty leaders call for Scripps chief to leave over USC merger plan. Report

Animal Health News

> Animal health test company Idexx Laboratories opens $35M addition. News

> Injectable brace for horses could speed up healing time. Item

> Advaxis pushes into animal care with cancer immunotherapy. Article

> FDA begins to guide nanotechnology in animal feed. More

> Merck's Bravecto, Bayer's Quellin chewables approved for dogs. Story

And Finally... The European Commission has a new report that says its priorities for the pharma industry include broader availability of biosimilars and orphan drugs and more public-private cooperation. Story

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…